HPV and Cervical Cancer: Updates on an Established Relationship (Q22305479)

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Estimates of the worldwide mortality from 25 cancers in 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Human papillomavirus infection and disease in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Dietary risk factors for invasive and in-situ cervical carcinomas in Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

[Hpv cofactors in cervical carcinogenesis].

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Papillomavirus vaccines in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Trends in cancer of the cervix uteri in Sweden following cytological screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

HPV DNA testing in cervical cancer screening: from evidence to policies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Health and economic implications of HPV vaccination in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

7 January 2021

A follow-up study of patients with cervical dysplasia

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

7 January 2021

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

7 January 2021

Oral contraceptive use and adenocarcinoma of cervix

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

7 January 2021

Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

7 January 2021

False negative rate of cervical cytologic smear screening as determined by rapid rescreening

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.11.1928

7 January 2021

Identifiers

DOI

10.3810/PGM.2008.11.1928

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4809572

OpenCitations bibliographic resource ID

4809572

1 reference